Applied Immune Sciences Inc. regulatory update

AISX received U.S. Patent No. 5,437,861 covering technology that enables removal of selected factors from whole blood or blood components. The technology consists of particulate silica that is pre-treated with an agent to enable the removal of factors such as pharmaceuticals and cytokines from whole blood or plasma. ...